CGT Archives - Title21 Health Solutions

May 13, 2025

Categories

Articles

Balancing Innovation and Safety in CGT: Insights from Title21’s Heather Purvis

As cell and gene therapies (CGTs) progress from the laboratory to patient care, clinical centers face unique challenges in adapting to these groundbreaking treatments. Explore insights from Title21’s Heather Purvis on balancing innovation and safety in CGT.

April 16, 2025

Categories

Articles

Preparing Clinical Centers for the Growing Demand of Cell and Gene Therapies: Insights from IBTV Panel Discussion

As cell and gene therapies (CGTs) progress from the laboratory to patient care, clinical centers face unique challenges in adapting to these groundbreaking treatments.

April 1, 2025

Categories

Articles

Title21 CEO Tony Pare Shares Insights on the 2025 Cell & Gene Therapy Investment Landscape

Explore the 2025 Cell & Gene Therapy investment landscape. Title21 CEO Tony Pare shares insights on trends, standardization & regulations from an IBTV panel.

November 20, 2024

Categories

Articles

Calculating the True ROI of Cell and Gene Therapy Software: A Comprehensive Guide

Cell and gene therapy (CGT) holds immense promise for revolutionizing medicine, offering potential cures for debilitating diseases like cancer and inherited genetic disorders.

Solutions by Industry

Featured Article

Contact Title21 Health Solutions

CGT

Balancing Innovation and Safety in CGT: Insights from Title21’s Heather Purvis

Preparing Clinical Centers for the Growing Demand of Cell and Gene Therapies: Insights from IBTV Panel Discussion

Title21 CEO Tony Pare Shares Insights on the 2025 Cell & Gene Therapy Investment Landscape

Calculating the True ROI of Cell and Gene Therapy Software: A Comprehensive Guide